| 000 | 01727cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030407.0 | ||
| 008 | 110504s2011 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.29.M.Sc.2011.Sh.E | ||
| 100 | 0 | _aSherine Wasfi Mikhail | |
| 245 | 1 | 0 |
_aEffects of strontium ranelate therapy on corticosteroid induced osteoporosis in Rats / _cSherine Wasfi Mikhail ; Supervised Salwa Abdelmonaem Elmessiry , Olfat Gamil Shaker , Hayam Ateya Abdelkawy |
| 246 | 1 | 5 | _aدور السترونتيوم رانيليت فى هشاشة العظام الناتجة عن تعاطى الكورتيزون فى فئران التجارب |
| 260 |
_aCairo : _bSherine Wasfi Mikhail , _c2011 |
||
| 300 |
_a239 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pharmacology | ||
| 520 | _aOsteoporosis is a disorder characterized by reduced bone mass, impaired bone quality and a liability to fracture. As osteoporosis is a major public health problem with serious medical and economic impact, there have been many advances in the management of osteoporosis over the past 10 years, but important care gaps still exist | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aGlucocorticoids | |
| 653 | 4 | _aOsteoporosis | |
| 653 | 4 | _aStrontium ranelate (Protelos) | |
| 700 | 0 |
_aHayam Ateya Abdelkawy , _eSupervisor |
|
| 700 | 0 |
_aOlfat Gamil Shaker , _eSupervisor |
|
| 700 | 0 |
_aSalwa Abdelmonaem Elmessiry , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aEnas _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c33764 _d33764 |
||